These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16919237)

  • 1. Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone.
    Hurst DR; Mehta A; Moore BP; Phadke PA; Meehan WJ; Accavitti MA; Shevde LA; Hopper JE; Xie Y; Welch DR; Samant RS
    Biochem Biophys Res Commun; 2006 Oct; 348(4):1429-35. PubMed ID: 16919237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription.
    Meehan WJ; Samant RS; Hopper JE; Carrozza MJ; Shevde LA; Workman JL; Eckert KA; Verderame MF; Welch DR
    J Biol Chem; 2004 Jan; 279(2):1562-9. PubMed ID: 14581478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation.
    Samant RS; Clark DW; Fillmore RA; Cicek M; Metge BJ; Chandramouli KH; Chambers AF; Casey G; Welch DR; Shevde LA
    Mol Cancer; 2007 Jan; 6():6. PubMed ID: 17227585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells.
    Hurst DR; Xie Y; Vaidya KS; Mehta A; Moore BP; Accavitti-Loper MA; Samant RS; Saxena R; Silveira AC; Welch DR
    J Biol Chem; 2008 Mar; 283(12):7438-44. PubMed ID: 18211900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor.
    Kovacs JJ; Murphy PJ; Gaillard S; Zhao X; Wu JT; Nicchitta CV; Yoshida M; Toft DO; Pratt WB; Yao TP
    Mol Cell; 2005 May; 18(5):601-7. PubMed ID: 15916966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment.
    Dai YS; Xu J; Molkentin JD
    Mol Cell Biol; 2005 Nov; 25(22):9936-48. PubMed ID: 16260608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterisation of the breast cancer metastasis suppressor, BRMS1.
    Smith J; Naseem R; Webb M
    Protein Expr Purif; 2009 Oct; 67(2):70-5. PubMed ID: 19401233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel BRMS1-homologue protein p40 as a component of the mSin3A/p33(ING1b)/HDAC1 deacetylase complex.
    Nikolaev AY; Papanikolaou NA; Li M; Qin J; Gu W
    Biochem Biophys Res Commun; 2004 Oct; 323(4):1216-22. PubMed ID: 15451426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone Deacetylase 6-Controlled Hsp90 Acetylation Significantly Alters Mineralocorticoid Receptor Subcellular Dynamics But Not its Transcriptional Activity.
    Jiménez-Canino R; Lorenzo-Díaz F; Jaisser F; Farman N; Giraldez T; Alvarez de la Rosa D
    Endocrinology; 2016 Jun; 157(6):2515-32. PubMed ID: 27100623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An acetylation site in the middle domain of Hsp90 regulates chaperone function.
    Scroggins BT; Robzyk K; Wang D; Marcu MG; Tsutsumi S; Beebe K; Cotter RJ; Felts S; Toft D; Karnitz L; Rosen N; Neckers L
    Mol Cell; 2007 Jan; 25(1):151-9. PubMed ID: 17218278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration.
    Roesley SN; Suryadinata R; Morrish E; Tan AR; Issa SM; Oakhill JS; Bernard O; Welch DR; Šarčević B
    Cell Cycle; 2016; 15(1):137-51. PubMed ID: 26771717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugging the HDAC6-HSP90 interplay in malignant cells.
    Krämer OH; Mahboobi S; Sellmer A
    Trends Pharmacol Sci; 2014 Oct; 35(10):501-9. PubMed ID: 25234862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells.
    Silveira AC; Hurst DR; Vaidya KS; Ayer DE; Welch DR
    Cancer Lett; 2009 Apr; 276(1):32-7. PubMed ID: 19070953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer metastasis suppressor 1: update.
    Meehan WJ; Welch DR
    Clin Exp Metastasis; 2003; 20(1):45-50. PubMed ID: 12650606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating molecular chaperone Hsp90 functions through reversible acetylation.
    Aoyagi S; Archer TK
    Trends Cell Biol; 2005 Nov; 15(11):565-7. PubMed ID: 16199163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FK228 inhibits Hsp90 chaperone function in K562 cells via hyperacetylation of Hsp70.
    Wang Y; Wang SY; Zhang XH; Zhao M; Hou CM; Xu YJ; Du ZY; Yu XD
    Biochem Biophys Res Commun; 2007 May; 356(4):998-1003. PubMed ID: 17397803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress on breast cancer metastasis suppressor 1 (BRMS1)].
    Yuan Y; Zhu ZY; Lai ZC; Zhang WX
    Yi Chuan; 2006 Sep; 28(9):1141-8. PubMed ID: 16963426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
    Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
    Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1.
    Hedley BD; Welch DR; Allan AL; Al-Katib W; Dales DW; Postenka CO; Casey G; Macdonald IC; Chambers AF
    Int J Cancer; 2008 Aug; 123(3):526-34. PubMed ID: 18470911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1).
    Samant RS; Debies MT; Hurst DR; Moore BP; Shevde LA; Welch DR
    Cancer Lett; 2006 Apr; 235(2):260-5. PubMed ID: 15978719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.